These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 16931934

  • 41. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response.
    Izopet J, Marchou B, Charreau I, Sauné K, Tangre P, Molina JM, Aboulker JP, Window (ANRS 106) Study Team.
    Antivir Ther; 2008; 13(4):537-45. PubMed ID: 18672532
    [Abstract] [Full Text] [Related]

  • 42. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.
    Simen BB, Simons JF, Hullsiek KH, Novak RM, Macarthur RD, Baxter JD, Huang C, Lubeski C, Turenchalk GS, Braverman MS, Desany B, Rothberg JM, Egholm M, Kozal MJ, Terry Beirn Community Programs for Clinical Research on AIDS.
    J Infect Dis; 2009 Mar 01; 199(5):693-701. PubMed ID: 19210162
    [Abstract] [Full Text] [Related]

  • 43. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J, Yue J, Wu S, Yan Y.
    Arch Virol; 2007 Mar 01; 152(10):1799-805. PubMed ID: 17619115
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Prevalence of minor variants of HIV strains at reverse transcriptase position 103 in therapy-naïve patients and their impact on the virological failure.
    Balduin M, Oette M, Däumer MP, Hoffmann D, Pfister HJ, Kaiser R.
    J Clin Virol; 2009 May 01; 45(1):34-8. PubMed ID: 19375978
    [Abstract] [Full Text] [Related]

  • 46. Genotypic resistance testing in HIV-infected pregnant women in an urban setting.
    Shah SS, Crane M, Monaghan K, McGowan JP.
    Int J STD AIDS; 2004 Jun 01; 15(6):384-7. PubMed ID: 15186583
    [Abstract] [Full Text] [Related]

  • 47. Primary drug resistance in antiretroviral-naïve injection drug users.
    Tossonian HK, Raffa JD, Grebely J, Viljoen M, Mead A, Khara M, McLean M, Krishnamurthy A, DeVlaming S, Conway B.
    Int J Infect Dis; 2009 Sep 01; 13(5):577-83. PubMed ID: 19111493
    [Abstract] [Full Text] [Related]

  • 48. Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.
    Soulié C, Assoumou L, Ghosn J, Duvivier C, Peytavin G, Ait-Arkoub Z, Molina JM, Costagliola D, Katlama C, Calvez V, Marcelin AG.
    AIDS; 2009 Jul 31; 23(12):1605-8. PubMed ID: 19487903
    [Abstract] [Full Text] [Related]

  • 49. Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors.
    Tambuyzer L, Azijn H, Rimsky LT, Vingerhoets J, Lecocq P, Kraus G, Picchio G, de Béthune MP.
    Antivir Ther; 2009 Jul 31; 14(1):103-9. PubMed ID: 19320243
    [Abstract] [Full Text] [Related]

  • 50. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
    Peuchant O, Thiébaut R, Capdepont S, Lavignolle-Aurillac V, Neau D, Morlat P, Dabis F, Fleury H, Masquelier B, ANRS CO3 Aquitaine Cohort.
    AIDS; 2008 Jul 31; 22(12):1417-23. PubMed ID: 18614864
    [Abstract] [Full Text] [Related]

  • 51. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes.
    SPREAD programme.
    AIDS; 2008 Mar 12; 22(5):625-35. PubMed ID: 18317004
    [Abstract] [Full Text] [Related]

  • 52. The V118I mutation as a marker of advanced HIV infection and disease progression.
    Zaccarelli M, Tozzi V, Lorenzini P, Forbici F, Narciso P, Ceccherini-Silberstein F, Trotta MP, Bertoli A, Liuzzi G, Marconi P, Mosti S, Perno CF, Antinori A.
    Antivir Ther; 2007 Mar 12; 12(2):163-8. PubMed ID: 17503658
    [Abstract] [Full Text] [Related]

  • 53. Study of the genotypic resistant pattern in HIV-infected women and children from rural west Cameroon.
    Turriziani O, Russo G, Lichtner M, Stano A, Tsague G, Maida P, Vullo V, Antonelli G.
    AIDS Res Hum Retroviruses; 2008 Jun 12; 24(6):781-5. PubMed ID: 18507527
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Analysis of HIV-1 sequences vertically transmitted to infants in Kisumu, Kenya.
    Steain MC, Wang B, Saksena NK.
    J Clin Virol; 2006 Aug 12; 36(4):298-302. PubMed ID: 16765640
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. PENTA guidelines for the use of antiretroviral therapy, 2004.
    Sharland M, Blanche S, Castelli G, Ramos J, Gibb DM, PENTA Steering Committee.
    HIV Med; 2004 Jul 12; 5 Suppl 2():61-86. PubMed ID: 15239717
    [Abstract] [Full Text] [Related]

  • 59. Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay.
    Villahermosa ML, Beck I, Pérez-Alvarez L, Contreras G, Frenkel LM, Osmanov S, de Parga EV, Delgado E, Manjon N, Cuevas MT, Thomson MM, Medrano L, Najera R.
    J Hum Virol; 2001 Jul 12; 4(5):238-48. PubMed ID: 11907381
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.